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Abstract
Background: Reports of osteoblastic tumours are limited to a few case reports in veterinary medicine.
Osteoblastoma-like osteosarcoma has been accepted by the World Health Organization as an intermediate form
between an osteosarcoma and osteoblastoma. This type of tumour indicates an osteosarcoma, that may resemble
osteoblastoma clinically, histologically, and radiologically and have the capability for metastasis. Osteoblastoma-like
osteosarcoma has not been described in veterinary medicine so far.
Case presentation: An eight-year old cat was presented due to progressive ataxia and paraparesis of the pelvic
limbs. Imaging confirmed a well-defined, extradural mass originating from the spinous process of the second
thoracic vertebra (T2) leading to severe compression of the spinal cord. Decompressive cytoreduction was achieved
by removal of the mass after dorsal laminectomy of T1. After recovering from an acute worsening 3.5 weeks after
surgery, the cat had an improved neurological status and the dorsal compression was resolved at follow-up 8
months later. A focal contrast enhancing lesion was still evident at the base of T2 spinous process and lung
metastasis was additionally suspected. Based on histopathological, radiographic, and clinical features, an “osteoblastoma-like
osteosarcoma” was suspected.
Conclusions: To the best of our knowledge, this is the first description of this tumour in veterinary medicine. In addition, this
case report highlights the difficulty in the diagnosis and definition of osseous neoplasia in cats and provides a literature
review.
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Background
Osteosarcoma represents the most common bone tumour
in cats, encompassing 70–80% of these neoplasms [1–6].
In one study investigating 85 feline spinal tumours, osteo-
sarcoma was the most common vertebral tumour and
represented the second largest fraction of all diagnosed tu-
mours [7].
In contrast, reports of osteoblastic tumours in the veter-
inary literature are limited, and include lesions reported in
three cats [4, 8], two dogs [9], mice [10], a pony [11] and a
hedgehog [12]. Similarly, in human medicine, osteoblas-
toma is a very rare primary bone neoplasia accounting for
less than 1 % of all bone forming tumours [13, 14]. In cats,
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Liu and others [4] identified an osteoid osteoma in a thor-
acic vertebral body.
Interestingly, in human literature, intermediate types
have been described that combines features of both,
osteosarcoma and osteoblastoma and led to a complex
definition or redefinition of different subtypes of osteo-
sarcoma and osteoblastoma. Table 1 gives a short over-
view over the described subtypes.
Osteoblastoma-like osteosarcoma (OBLOS) has been
defined in human literature as a malignant tumour, that
share features between both, osteosarcoma and osteo-
blastoma and have the potential for metastasising [19,
23]. The term “aggressive osteoblastoma” was first intro-
duced into veterinary literature describing a vertebral
neoplasia in a cat by Kim et al. [24]. Aggressive osteo-
blastoma invades adjacent tissue and recurs but, in con-
trast to OBLOS, does not metastasize [25]. Although
malignant transformation of osteoblastomas with pul-
monary metastases have been infrequently reported in
human medicine [26–29], this has not been described in
veterinary medicine.
In this case report, we describe an osseous neoplasia
arising from a thoracic vertebra of a cat that histologi-
cally is compatible with an osteoblastoma. However, the
clinical and radiological behaviour suggest that the mass
represents an intermediate form of osteoblastoma and
osteosarcoma previously described in human medicine
(i. e. OBLOS, “osteosarcoma resembling osteoblastoma”
[19, 20]) but still novel in veterinary medicine and add
important information to the sparse literature on osse-
ous neoplasia existing for the feline patient.
Case presentation
Clinical history
An eight-year old female spayed domestic short hair cat
was presented to the Small Animal Clinic of the Vet-
suisse Faculty of the University of Bern, Switzerland, due
to progressive gait abnormalities of both pelvic limbs.
The first clinical sign, consisting of frequent stretching
of the pelvic limbs, has been intermittently observed by
the owner over the last 2 months prior to presentation.
One week prior to presentation the cat acutely wors-
ened, was reluctant to jump and to climb stairs and
seemed to be painful. Additionally, an increased water-
intake and periuria have been observed by the owner.
Clinical findings and investigation
At the time of presentation, vital parameters were within
normal limits. Neurological examination revealed mild
ambulatory paraparesis, moderate pelvic limb proprio-
ceptive ataxia, and reduced proprioceptive positioning
and hopping response in both pelvic limbs. The
remaining neurological examination was unremarkable
and no spinal hyperesthesia could be detected on palpa-
tion. Neurological findings were consistent with a lesion
within the third thoracic and third lumbar spinal cord
segments. Initial differential diagnoses included neopla-
sia, intervertebral disk protrusion and an inflammatory
process. Haematology and serum biochemistry revealed
mild changes, including eosinophilia (1.94 × 109/l; range:
0–1.5 × 109/l), and an elevated aspartate transaminase
(117 IU; range: 12–61) and creatinine kinase (5812 IU;
range: 0–596) activity. Serological testing for feline im-
munodeficiency virus and feline leukaemia virus were
negative. Thoracic radiographs revealed no abnormalities
of the intrathoracic organs, although a quite well de-
fined, round geographic radiolucent lesion was identified
at the base of the spinous process of the second thoracic
vertebra (T2) expanding into the area of the vertebral
canal (Fig. 1). MRI using a 1.0 Tesla open permanent
magnet (Philips HFO Panorama, Philips Medical Sys-
tems, PC Best, Netherlands) of the thoracolumbar area
revealed an extramedullary space occupying lesion at the
level of T1/2, causing a severe dorsal compression and
deformation of the spinal cord (Fig. 2). The lesion was
slightly heterogeneous and almost isointense to the
spinal cord on T1- and T2-weighted and hyperintense
on T2*- and STIR- sequences. The epicenter of the le-
sion was suspected to be at the level of the dorsal lamina
of T2. For a better description of bony involvement and
to rule out metastases, the MRI was immediately
followed by a CT-examination of the thorax and abdo-
men. In CT, the above described lesion had a soft tissue
Table 1 Overview of the described intermediate types between
osteosarcoma and osteoblastoma in human literature
Source Definition
Schajowicz and Lemos
(1976) [15]
Malignant osteoblastoma
Mirra and others
(1976) [16]
Pseudomalignant osteoblastoma
Revell and Scholtz
(1979) [17]
Aggressive osteoblastoma
Dorfman and Weiss
(1984) [18]
Subclassification in:
1. low-grade osteoblastoma-like osteosarcomas
2. pseudomalignant osteoblastoma
3. malignant transformation of initially benign
osteoblastoma to a high-grade malignant
osteosarcoma
4. locally aggressive/ malignant osteoblastoma
Bertoni and others
(1985) [19]
Osteosarcoma resembling osteoblastoma
Bertoni and others
(1993) [20]
Osteoblastoma-like osteosarcoma
Bertoni and others
(1993) [21]
Osteoblastoma with cartilaginous matrix
De Oliveira and others
(2007) [22]
Atypical osteoblastoma
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density (HU 60–65) (Fig. 3). The mass showed severe
and relatively homogeneous contrast enhancement.
The final radiographic diagnosis was an expansile
extramedullary space occupying mass centered in the
cancellous bone of the base of the dorsal spinous process
of T2 causing severe compression of the spinal cord
from dorsal and dislocation and deformation of the cau-
dodorsal lamina of T1. No signs of metastatic disease
were detected. Cerebrospinal fluid was collected from
the cerebellomedullary cistern and its analysis was
unremarkable.
Differential diagnosis
Considering the signalment, the clinical and imaging
presentation, the main differential diagnosis was a verte-
bral neoplasia, i. e. round cell tumour, osteoblastoma or
osteosarcoma.
Treatment
The cat was discharged with gabapentin (5 mg/kg TID
po) and restriction of exercise was recommended. A sur-
gical exploration was suggested and performed fortnight
after diagnosis.
During surgery, a large dorsal laminectomy of T1
(modified Funkquist type B) was performed. A white,
solid bulging mass originating from the lamina of T2
was identified on the excised bony segment (see Fig. 4).
After its resection, the underlying spinal cord showed a
dorsal indention at the level of T2. Based on the intraop-
erative findings, the mass seemed to be macroscopically
completely removed, therefore a caudal extension of the
laminectomy over T2 was not performed. The cat recov-
ered uneventfully, and the early post-surgical treatment
included fentanyl-CRI (5 μl/kg/h), gabapentin (5 mg/kg
TID po), prednisolone (1 mg/kg SID po) and omeprazole
(1 mg/kg BID iv). After the first 24 h following surgery,
fentanyl was substituted with buprenorphine (.01 mg/kg
TID iv).
Histopathological findings
For histological examination the resected material was
fixed in 10% buffered formalin, decalcified (Rapid
Fig. 1 Right to left-lateral radiograph cranial aspect of the thoracic
vertebral column. A quite well-defined radiolucent lesion at the level
of the base of the spinous process (SP) of the 2nd thoracic vertebra
(T2) is visible (arrows). Note the absent opacity originating from the
dorsal lamina of T2 and of the facet joints cranial to the lesion. The
base of the spinous process of T1 and the area dorsal to the lesion
appear diffusely sclerotic
Fig. 2 MRI at the level of T1/2. An extramedullary lesion (arrowheads) invading the ventral medullary space of the spinous process of T2 with homogenous
contrast enhancement (b, d) is visibile. Medullary invasion is best outlined after contrast injection (b, d). A severe dorsal compression of the spinal cord (*) exists
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Decalcifier, J.T. Baker®), routinely processed, and stained
with hematoxylin & eosin and van Gieson’s stain.
At first, a periosteal osteosarcoma was diagnosed. This
diagnosis was based on the periosteal covering of the tu-
mour’s surface (Fig. 5a).
After discussion of the case in the context of the diag-
nostic imaging, histology was re-evaluated by a patholo-
gist specialized in bone pathology. Histopathologically,
this specimen was an ovoid, low-grade tumor resembling
neoplastic cells of osteogenic origin that were spindled
and polygonal cells having mild anaplastic features.
Tumor cells that exhibit few mitotic figures form and
entrap themselves in random microscopic deposits of
osteoid matrix. Tumor expansion toward the spinal
canal has induced osteoclastic remodeling and removal
of the bony support for the periosteal covered surface.
Neoplastic cells revealed varying patterns within the
mass; close to the periosteum the mass was composed of
larger lakes of osteoid surrounded by polygonal osteo-
blasts and occasional multinucleated osteoclasts (Fig. 5b).
Further, apart from the periosteum, osteoid production
was less, and the tumour was composed of short fasci-
cles of neoplastic spindle cells surrounding small islets
of osteoid matrix; in addition, few polygonal cells, re-
sembling osteoblasts and few osteoclasts were present
(Fig. 5c).
Based on the histopathological findings, an osteoblas-
toma was diagnosed.
Outcome and follow-up
The cat was discharged 2 days after surgery with an am-
bulatory paraparesis and proprioceptive ataxia in both
pelvic limbs. Further medical treatment consisted in
gabapentin (5 mg/kg TID po for 2 weeks, thereafter slow
withdrawal over 2 weeks), prednisolone (1 mg/kg SID po
for 5 days, thereafter slow withdrawal over 15 days) and
omeprazole (1 mg/kg BID po during prednisolone-
treatment). Strict cage rest for the first weeks after sur-
gery and physiotherapy were recommended. At the first
follow-up 2 weeks after surgery, the cat experienced a
clear improvement of the neurological signs, showing
only a mild ataxia in both pelvic limbs. Due to the tem-
perament of the cat, physiotherapy could not be per-
formed. Nevertheless, after initial improvement, the cat
suffered an acute transient deterioration 3.5 weeks after
surgery which improved with strict rest. At the clinical
and imaging follow-up 8 months after surgery, the cat
had only a mild ataxia in the pelvic limbs. CT revealed a
well-defined, in respect to the spinal cord isodense le-
sion ventrally demarcated by a hyperdense rim within
Fig. 3 Sagittal reconstruction (a, b) and transverse (c) CT-images of the cranial thoracic vertebral column presented in soft tissue- (a, c) and bone
window post contrast (b). A thin, hyperdense line separates the bilobed lesion ventrally from the underlying spinal cord and is the remnant of
the ventral and cranial displaced dorsal lamina of T2 (b,c). Note the thinning and deformation of the cortex of the spinous process of T2 and its
widening of the medullary cavity at the base (c)
Fig. 4 Caudal view on the resected spinous process of T1 (SP1).
Note the enlargement of the medullary cavity at the spinous
process´ base and the brownish and smooth surface of the
tumour (*)
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the base of the spinous process of T2, that was homoge-
nously contrast enhancing, indicating recurrence of the
tumour (Fig. 6a, b). Furthermore, a dorsal T1/2 vertebral
luxation with synostosis was diagnosed. Nevertheless,
MRI showed a resolution of the dorsal compression of
the spinal cord (Fig. 6c). Additionally, a triangular
ground glass opacity lung lesion ventrally within the left
caudal lobe was visible. (Fig. 6d).
Due to the current good quality of the cat’s life, the
owner denied further workup of the pulmonary changes,
as well as any additional treatment. As metastatic lung
disease could not be excluded, a histopathological re-
evaluation including immunohistochemistry was per-
formed. Primary antibodies used were COX-2, to
differentiate osteoblastoma from low-grade osteosar-
coma and Collagen I, to confirm osteoid matrix produc-
tion and therefore osseous origin of the neoplasia. Heat
induced epitope retrieval (devax and HIER Buffer H at
pH 9, Thermoscientific) for unmasking antigens was
used. Negative immunohistochemical controls for each
sample were prepared by omitting the primary antibody.
For each primary antibody, a known positive control sec-
tion was included in each immunolabeling assay.
COX-2 immunostaining revealed strong positivity of
few neoplastic cells entrapped in a focal area of woven
bone, while the rest of the neoplastic cells were negative.
Collagen I immunostaining was diffusely positive within
the cortical bone next to the tumoral mass, the reactive
Fig. 5 Histological presentation, Hematoxylin & Eosin: a The expansively growing neoplastic mass develops (arrows) within the intertrabecular
spaces of the irregularly arranged woven bone (*), which is attached to the fibrous periosteum in which chondrocytes (^) and osteoblasts are
present. ‡ = base of the spinous process of T1. b Close to the periosteum the tumour is composed of larger lakes of amorphous osteoid (*)
surrounded by polygonal osteoblasts and occasional multinucleated osteoclasts (+) 400x. c Van Gieson: Mass further away from the periosteum.
Osteoid production was less and short fascicles of spindle cells or polygonal cells (yellow) surround small islets of osteoid (red) 100x
Fig. 6 Follow-up diagnostic imaging. Arrowheads outline a well demarcated, hypodense bone lesion at the base of the spinous process (SP) of
the 2nd thoracic vertebra (T2), which is ventrally delineated by a bony rim (arrow, a). Note the dorsal subluxation and synostosis between the 1st
(T1) and 2nd (T2) thoracic vertebra. The lesion takes up contrast homogenously (b). Spinal cord compression (*) is no longer existing (c). Lung
changes were present in the left (L) caudal lung lobe (‡, d)
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woven bone and the extracellular osteoid matrix of the
tumour (Fig. 7). In summary, considering histopatho-
logical and diagnostic imaging findings, the inconclusive
immunoreactivity of the sample and the possible lung
metastasis, an OBLOS arising from T2 was suspected, al-
though it could not be confirmed.
At the date of submission (i. e. nearly 23 months after
initial presentation) the cat was still alive and showed a
good quality of life.
Discussion
Osteosarcoma is the most common vertebral tumour in
the cat. In contrast, veterinary reports of osteoblastic tu-
mours are restricted to a few case reports [8–12, 24, 30].
Definitive diagnosis of primary bone tumours is chal-
lenging. These difficulties are highlighted in this case re-
port, in which initially, based on the histopathological
findings, a periosteal osteosarcoma was diagnosed. This
diagnosis was based on the periosteal covering of the
mass. The first diagnosis led to some concerns, since
based on imaging, the lesion seemed to originate from
the cancellous bone of T2, rather than its surface. There-
fore, a pathologist specialized in bone pathology was
consulted for a second opinion, who diagnosed finally an
osteoblastoma arising from the cancellous bone of T2
with slow expansile growth that, in turn, has been re-
sulted in encroachment of the border of the spinous
process into the spinal canal causing clinical signs.
After a lung metastasis was considered during the follow
up, a further re-evaluation of the specimen via immuno-
histochemistry was performed, since an osteoblastoma
would not be compatible with metastatic behaviour. Colla-
gen 1-immunostaining confirmed the production of
osteoid matrix by the tumoral cells, and therefore the os-
seous origin, being Collagen I the main fibrillar compo-
nent of bone extracellular matrix. In human medicine,
COX-2 positivity has been used to distinguish between ag-
gressive osteoblastoma and low-grade osteosarcoma, being
the first COX-2 positive and the second COX-2 negative
[31]. Kim et al. in 2017 [24] used this immunohistochemi-
cal method to diagnose an aggressive osteoblastoma in a
cervical vertebra in an Angora cat. Unfortunately, in our
case immunohistochemistry failed to result in a definitive
diagnosis. COX-2 immunostaining revealed only few al-
though strongly positive neoplastic cells entrapped in a
focal area of woven bone, while the rest of the neoplastic
cells were negative. Since the tissue underwent decalcifica-
tion, we hypothesized that the lack of diffuse positivity
could be the consequence of an altered immunohisto-
chemical reactivity of the tissue leading to a false negative
result in most of the sample. Indeed, in the presented case,
a rapid decalcifying solution containing hydrochloric acid
was used. Rapid decalcifiers are detrimental for antigenic-
ity, but have the advantage of a fast sample processing,
leading to a quicker histological interpretation and
therefore preferred in clinical settings. EDTA decalci-
fying solution has a long decalcification time but pre-
serves antigens well and should be preferred in cases
in which immunohistochemistry is planned [32]. Un-
fortunately, no detailed information about decalcifica-
tion process and IHC methods are available in the
report of Kim et al. [28].
Based on the histological findings, the imaging features
and the potential metastatic behaviour, an OBLOS was
considered to be the most likely diagnosis. According to
the grading by Gambarotti et al. [23], the World Health
Organization in its 4th WHO classification of tumours of
soft tissue and bone (2013) listed OBLOS within the group
of conventional (high-grade) osteosarcoma. Nevertheless,
Gambarotti et al. [23] found in his study OBLOSs that
could be subtyped as both, low-grade and high-grade-
osteosarcomas and concluded, that the presence of histo-
logical areas of conventional (high-grade) osteosarcomas
are the only predictor for aggressiveness. Osteoblastoma,
aggressive osteoblastoma and OBLOS can share similar
histological features, therefore they can be indistinguish-
able on biopsies. Even if recurrence is described in all
three types of tumours, only OBLOS have been shown to
metastasize. Permeation of the surrounding bone is an im-
portant feature of osteosarcoma [19] and, thus, an often
mentioned point in borderline osteoblastic tumours [19,
20, 33]. The histopathological analysis of the specimens in
our case does not confirm permeation of the bone of T1
and radiologic analysis does not reveal aggressive bone le-
sions of T2. This would support the diagnosis of osteo-
blastoma. However, the clinical follow up, suggesting
recurrence with pulmonary changes not excluding
Fig. 7 Immunohistochemistry (IHC) for Collagen I. Diffuse positivity
evidenced by the brown colour of the reactive woven bone and the
extracellular osteoid matrix of the tumour, 200x. Hematoxylin was
used for counterstaining
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metastasis, together with the unreliable COX-2 immuno-
staining made an OBLOS a more likely differential
diagnosis.
No other potential neoplastic lesions were detected on
the whole body CT-scan at the time of first presentation;
thus, it was presumed that the lung lesion in the follow-
up CT scan 9months later might represent a metastasis
of the vertebral bone lesion. The diagnosis of metastatic
lung disease tumours is more challenging in cats com-
pared to dogs [34]. In contrary to dogs, multiple nodular
lung metastases seem to be rare in cats. Number, distri-
bution, density, size, demarcation, localisation, and con-
trast uptake of metastatic lung lesions in cats are, in
contrary to primary lung neoplasia - especially the
adenocarcinoma [35]- hardly documented in the litera-
ture. It is reported, that lung metastasis are often less
well delineated in cats, similar to the lung nodule in the
case presented here [34].
Reasons for the difficulties in diagnosing primary bone
tumours are on one side the overlap in histopathological
and diagnostic imaging features among the different
types (i. e. osteoblastoma and osteoid osteoma, low-
grade osteosarcoma and aggressive osteoblastoma) [9,
19, 20, 22, 31, 36–38] and on the other side the ability of
malignant transformation [27, 29, 38–40]. In human
medicine, this results in the definition or redefinition of
different subtypes of osteosarcoma and osteoblastoma
[18, 22, 41].
Rosado et al. in 2000 [38] provided a review about the
difficulty in differentiating osteoblastoma from osteosar-
coma for the human medicine. According to the authors,
the tumour’s mitotic activity and its permeation of adja-
cent tissue are the most important criteria: osteoblas-
toma reveals no mitotic activity and does not permeate
the surrounding tissue whereas osteosarcoma does.
Nevertheless, they confirmed the existence of a “biologic-
ally intermediate or indeterminate group”. Dorfman and
Weiss [18] proposed a classification of human borderline
osteoblastic tumours into 4 categories (see Table 1). In
the cat presented here, OBLOS was considered to be a
differential diagnosis to aggressive osteoblastoma. In hu-
man literature, the term OBLOS indicates an osteosar-
coma, that may resemble osteoblastoma clinically,
histologically and radiologically and have the capability
for metastasis. However, conflicting information con-
cerning the capacity to metastasize of this type of
tumour exists [18, 19, 23–25, 27, 33, 40, 42–46].
In line with our findings, osteoblastoma usually pre-
sents as a well-defined, rounded, lytic, radiolucent lesion
originating in the medullary part of the bone with vary-
ing amounts of surrounding sclerosis in radiographic
analysis [38, 47]. In contrast, osteosarcomas are typically
destructive with an accompanying periosteal reaction
[38]. Furthermore, Rosado et al. in 2000 [38] postulated,
that in human patients spinal osteoblastomas have a pre-
dilection site to the posterior elements of the vertebra,
including the spinal process, as in the cat presented in
this case report, whereas osteosarcomas tend to initially
affect the vertebral body. MRI features of spinal osteo-
blastomas are usually nonspecific and highly variable
[47]. Signal intensity in T2-weighted sequences depends
on the level of matrix mineralization [48], which is con-
clusive with the presented case here, that revealed barely
mineralized matrix and in turn isointensity to the spinal
cord in both T1- and T2-weighted sequences. The well-
defined borders of osteoblastomas in CT resemble the
histological lack of infiltration at the lesion-host bone
interface [38] as seen in the case presented here. OBLOS
shares radiological features with both, osteoblastoma
and osteosarcoma [19, 44]. Ozger et al. in 2016 [44] pos-
tulated, OBLOS to be well- or ill-defined, lytic and
sharply demarcated on CT and radiographs. Typical
radiographic features of osteosarcoma, like periosteal re-
action and/or cortical destruction is a facultative feature
in OBLOS. Thinning of the cortex might be present due
to the expansile growth [44]. In contrast, OBLOS typic-
ally reveals a T1-hypointensity and an intermediate in-
tensity in T2-weighted sequences with heterogeneous
contrast enhancement, whereas osteoblastoma shows
T1- and T2-iso- to hypointensity with permanent con-
trast enhancement [44]. Thus, an osteoblastoma at the
base of T2 was initially suspected based on radiological
examination. On the other hand, in support to the diag-
nosis of OBLOS, osteoblastoma does not metastasize to
other regions of the body [49]. Nevertheless, several re-
ports of osteoblastomas in human medicine, indicate
malignant transformation and metastatic behaviour. Ber-
toni et al. in 1985 [19] described 17 bone tumours, that
did not show any permeation of the surrounding bone
but in several cases metastatic behaviour. Mitchell and
Ackerman in 1986 [28] reported a “metastatic osteoblas-
toma” in a 15-year old boy; Kunze et al. in 1996 [27] and
Wozniak et al. in 2010 [29] described metastases follow-
ing malignant transformation of human osteoblastomas.
Metastases have been documented as well in OBLOSs
[19, 23]. Interestingly, in all reported cases “osteoblasto-
mas” metastasize into the lungs [26]. The sparsely exist-
ing literature indicate that metastatic behaviour of
initially diagnosed osteoblastomas have a low incidence
with 2 out of 306 (0.7%) in the large cohort study of hu-
man patients from Lucas et al. in 1994 [14]. In our feline
case, pulmonary metastasis could not be excluded, there-
fore, without histopathological confirmation we can only
speculate that the presented cat suffered from an
OBLOS.
Only few reports on osteoblastic tumours have been
published in veterinary literature [4, 8–12]. In accord-
ance to the radiological and histopathological findings
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with special regard to the lung changes and the recur-
rence, a borderline osteoblastic tumour, sharing most
criteria with an OBLOS [19] is a valid diagnosis.
En bloc resection of cervical osteoblastoma has been re-
ported to be the treatment of choice in human medicine
[50–52]. Nevertheless, complete excision might be chal-
lenging in the vertebral column due to the risk of destabil-
isation and spinal cord damage. In the presented case, a
dorsal laminectomy of the first and second thoracic verte-
brae was initially planned. During the removal of the
spinous process of T1, the compressive mass was simul-
taneously detached. In order to avoid destabilization, the
dorsal laminectomy was therefore not extended over T2,
since the degree of spinal cord decompression was be-
lieved to be satisfying. Indeed, the cat improved clinically
over the following days. Although strict rest was firmly
recommended, the cat was still allowed to run outside.
After 3.5 weeks the cat suffered from a sudden, yet transi-
ent neurological deterioration. Due to the clinical im-
provement on conservative treatment, no further work-up
was performed. At the follow-up performed 8 months
later, a chronic subluxation in the surgery area was diag-
nosed. It is reasonable to believe that the subluxation hap-
pened at the time of the neurological worsening. Although
reimaging indicated a recurrence of the mass, the spinal
cord was still not compressed. Surgical treatment of spinal
bone tumour reported in cats includes an hemilaminect-
omy [24] in a cervical aggressive osteoblastoma and an
hemilaminectomy followed by a vertebral replacement in
a L1 osteosarcoma [53]. Recurrence was described two
and 3 years after the initial surgery, respectively. In the lat-
ter case an additional vertebrectomy was performed 6
months after recurrence and the cat was alive and
recurrence-free 5.25 years after the initial hemilaminect-
omy [53]. Levy et al. in 1997 [54] suspected the difficulty
for total excision of vertebral osteosarcoma might be
reasonable for the reported better prognosis of cats
with appendicular osteosarcoma [3, 55]. Rossmeisl
et al. in 2006 [56] found that cytoreductive surgery
can achieve a good palliation of clinical signs and
spinal cord dysfunction, nevertheless, incomplete exci-
sion occurred frequently. The authors found a strong
correlation between tumour phenotype and the sur-
geon’s impression of total resection, since subtotal re-
section was suspected postoperatively in all malignant
and total resection in all benign neoplasms [56].
Based on the intraoperative findings, the whole mass
was believed to be resected in the presented case. An
important limitation is the lack of immediate postsur-
gical imaging to assess more objectively the macro-
scopical amount of tumour tissue removed.
In conclusion and in respect to the entire radiological,
clinical and pathological findings, the vertebral neoplasia
in the reported cat, best resembles what in human
medicine is mainly known as OBLOS [19] and it repre-
sents the first description in a feline patient.
Our case report depicts the challenges in diagnosing
primary bone tumours and gives a wide overview about
the current discussion on their definitions and classifica-
tions. The primary bone neoplasia in this cat clearly
compounds features of both osteoblastoma and osteosar-
coma and thus might represent a novel subtype of pri-
mary bone tumours. Additionally, it contributes
interesting features to the sparsely existing literature on
feline primary bone tumours. Malignant transformation
of an osteoblastoma have not been described in veterin-
ary medicine yet. This case report also reflects the al-
most daily clinical challenge in estimating the dignity of
a lesion, which is in the end more important than the
correct naming.
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